News in brief

Kaneka receives Canadian NPN for Floradapt Cardio

By Stephen Daniells contact

- Last updated on GMT

© Getty Images / Moussa81
© Getty Images / Moussa81

Related tags: Probiotics, Canada

Health Canada’s Natural Health Products Directorate (NHPD) has issued a Class III approval for Kaneka’s Floradapt Cardio probiotic.

Identified by the Natural Product Number (NPN) 80096187, Floradapt Cardio​ contains Lactobacillus plantarum​ KABP-011, KABP-012, and KABP-013.

“With this approval from Health Canada, we are providing dietary supplement companies an innovative way to engage the cardiovascular market,”​ said Mike Kolifrath, Vice President, Sales and Marketing of the Probiotics Division at Kaneka.

The product’s NPN allows for the following claims in Canada (the claims are not valid for the USA):

• Helps to reduce levels of total cholesterol in men and women with hypercholesterolemia.

• Helps support healthy cholesterol level in hypercholesterolemic patients

• Supports cardiovascular health by contributing to healthy serum cholesterol in hypercholesterolemic patients

• Helps support intestinal / gastrointestinal health

• Could promote a favorable gut flora

• Source of probiotics

Related news

Related products

show more

Expanding Probiotic Possibilities with DE111®

Expanding Probiotic Possibilities with DE111®

Deerland Probiotics & Enzymes | 24-Mar-2020 | Technical / White Paper

DE111® is a clinically studied strain of Bacillus subtilis that delivers benefits for digestive health, immune health, regularity and sports nutrition....

EXPERT’Biotics for babies

EXPERT’Biotics for babies

Lallemand Health Solutions | 16-Mar-2020 | Technical / White Paper

Lallemand Health Solutions (LHS) has a large portfolio of EXPERT’Biotics solutions, including Lacidofil®, Probiokid®, Lafti B94®, S. boulardii, L. rhamnosus...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars